-
61
Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells.
Published 2025-01-01“…<h4>Background</h4>Hypoxia in tumor cells is linked to increased drug resistance and more aggressive behavior. In pancreatic cancer, the tumor microenvironment is notably hypoxic and exhibits strong immunosuppressive properties. …”
Get full text
Article -
62
Comment on “Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection”
Published 2024-03-01Get full text
Article -
63
Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer
Published 2021-01-01“…Enhancer of zeste homolog 2 (EZH2) is abnormally highly expressed in pancreatic cancer (PC). However, it is not ideal to treat PC by inhibiting EZH2. …”
Get full text
Article -
64
NFE2-driven neutrophil polarization promotes pancreatic cancer liver metastasis progression
Published 2025-02-01“…Summary: Pancreatic cancer liver metastasis is an important factor leading to dismal prognoses. …”
Get full text
Article -
65
5 Fluorouracil‐loaded biosynthesised gold nanoparticles for the in vitro treatment of human pancreatic cancer cell
Published 2019-10-01Subjects: Get full text
Article -
66
Impact of Order Set on Exocrine Pancreatic Insufficiency in Chronic Pancreatitis, Pancreatic Cancer, and Pancreatic Resection
Published 2025-01-01Subjects: Get full text
Article -
67
-
68
Early Detection of Pancreatic Cancer: Opportunities Provided by Cancer-induced Paraneoplastic Phenomena and Artificial Intelligence
Published 2023-10-01Subjects: Get full text
Article -
69
Improving molecular subtypes and prognosis of pancreatic cancer through multi group analysis and machine learning
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
70
-
71
Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy
Published 2010-01-01“…Pancreatic cancer remains a challenge both diagnostically and therapeutically. …”
Get full text
Article -
72
Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells
Published 2023-09-01Subjects: “…pancreatic cancer…”
Get full text
Article -
73
Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019
Published 2022-01-01“…We set out to find E. coli BSI’s risk factors in pancreatic cancer to provide valuable experience. Methods. …”
Get full text
Article -
74
TWIST1 regulates HK2 ubiquitination degradation to promote pancreatic cancer invasion and metastasis
Published 2025-02-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
75
Correlations among PPAR𝜸, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer
Published 2012-01-01“…In this study we aimed to evaluate the expression of PPARγ, DNMT1, and DNMT3B and their correlation with clinical-pathological features in patients with pancreatic cancer (PC), and to define the effect of PPARγ activation on DNMTs expression in PC cell lines. qRT-PCR analysis showed that DNMT3B expression was downregulated in tumors compared to normal tissues (𝑃=0.03), whereas PPARγ and DNMT1 levels did not show significant alterations in PC patients. …”
Get full text
Article -
76
Response to: Comment on “Dynamics of Serum CA 19-9 in Patients Undergoing Pancreatic Cancer Resection”
Published 2024-06-01Get full text
Article -
77
The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
78
Treatment and Outcomes of Pancreatic Cancer in Armenia: A Retrospective Study From Resource-Limited Settings
Published 2025-01-01“…The information was obtained from the medical records of the patients with pancreatic cancer treated at these centers during January 1, 2010-January 1, 2022. …”
Get full text
Article -
79
Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
80
Assessment of Nutritional Status, Digestion and Absorption, and Quality of Life in Patients with Locally Advanced Pancreatic Cancer
Published 2017-01-01“…To provide a comprehensive quantitative assessment of nutritional status, digestion and absorption, and quality of life (QoL) in patients with locally advanced pancreatic cancer (LAPC). Methods. Sixteen patients with LAPC were prospectively assessed for weight loss (WL), body mass index (BMI), fat-free mass index (FFMI), handgrip strength (HGS), dietary macronutrient intake, serum vitamin levels, resting and total energy expenditure (REE and TEE, indirect calorimetry), intestinal absorption capacity and fecal losses (bomb calorimetry), exocrine pancreatic function (fecal elastase-1 (FE1)), and gastrointestinal quality of life (GIQLI). …”
Get full text
Article